The US government will rely more on a shrunken domestic manufacturing base for federal procurement of essential medicines under a “Buy American” executive order President Trump signed 6 August that leaves many details unclear but nonetheless drew criticism from global manufacturers.
The novel coronavirus pandemic brought white-hot scrutiny to the nation's ability to protect access to needed medicines for US patients,...





